STOCK TITAN

Orchid Island Capital (ORC) Form 4 Filings

ORC NYSE

Here are the Form 4 insider transactions from Orchid Island Capital, Inc. (ORC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ORC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ORC filings page.

Rhea-AI Summary

Orchid Island Capital, Inc. director Ava L. Parker acquired 2,548 deferred stock units on October 29, 2026, issued in lieu of the company’s monthly dividend pursuant to her election. The reported transaction price was $5.03 per share, and Parker held 136,472 deferred stock units following the transaction. Each unit represents a right to receive one common share. The units are 100% vested but become payable only upon the earlier of a change of control or Parker’s death, disability, or separation from service as a director.

Rhea-AI Summary

Orchid Island Capital, Inc. director Ava L. Parker received 5,755 deferred stock units on October 1, 2026, and 2,183 on September 30, 2026. The September 30 units were issued in lieu of the monthly dividend pursuant to Parker’s election; each deferred stock unit represents the right to receive one common share.

Rhea-AI Summary

Paula Morabito, a director of Orchid Island Capital, Inc. (ORC), received a grant of 5,755 deferred stock units on October 1, 2026, bringing her directly held balance to 61,441 deferred stock units. Each unit represents a right to receive one share of common stock. The units are 100% vested but become payable only upon the earlier of a change of control or Ms. Morabito’s death, disability, or separation from service as a director.

Rhea-AI Summary

Orchid Island Capital, Inc. (ORC) director Frank P. Filipps received a compensation-related grant of 5,755 deferred stock units on October 1, 2026. Each unit represents a right to receive one common share. The units are 100% vested and become payable upon the earlier of a change of control or Mr. Filipps’s death, disability, or separation from service as a director. His reported deferred stock unit balance following the grant was 59,630.

Rhea-AI Summary

Orchid Island Capital, Inc. director W. Coleman Bitting acquired 5,755 deferred stock units on October 1, 2026, bringing his reported direct holdings to 59,630 deferred stock units. Each unit represents a right to receive one common share. The units are 100% vested but become payable only upon the earlier of a change of control or Bitting’s death, disability, or separation from service as a director.

Rhea-AI Summary

Orchid Island Capital, Inc. (ORC) Chief Executive Officer and director Robert E. Cauley reported vesting 1,276.1 Performance Units on September 25, 2026, resulting in the issuance of 1,276 common shares. Cash was paid in lieu of issuing fractional shares, based on the common stock’s closing price on September 24, 2026. Following the transaction, his reported holdings were 125,719.28 Performance Units and 228,260 common shares.

Rhea-AI Summary

Orchid Island Capital, Inc. Chief Financial Officer and director Haas G Hunter IV had 1,189 Performance Units vest on September 25, 2026, resulting in the issuance of 1,189 common shares. The vesting also involved 468 common shares withheld for tax obligations at the reported price of $5.77 per share, the September 24, 2026 closing price. The reported position following the transaction was 96,750.95 Performance Units. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Orchid Island Capital, Inc. (symbol: ORC) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Parker Ava L reported acquisition or exercise transactions in this Form 4 filing.

Orchid Island Capital director Ava L. Parker received a grant of 1,791 Deferred Stock Units on July 31, 2026, at $6.63 per unit. Each unit represents the right to receive one share of common stock and was issued in lieu of the company’s monthly dividend under her election. The units are 100% vested but become payable only upon a change of control or Parker’s death, disability, or separation from service as a director. Following this award, she holds 124,131 deferred stock units.

Rhea-AI Summary

FILIPPS FRANK P reported acquisition or exercise transactions in this Form 4 filing.

Orchid Island Capital director Frank P. Filipps received a grant of deferred stock units as part of his director compensation. On this date, he was awarded 3,586 deferred stock units, each representing the right to receive one share of Orchid Island Capital common stock.

These deferred stock units are fully vested but will only be paid out upon a change of control of the company or upon his death, disability, or separation from service as a director. Following this award, Filipps directly holds 53,875 deferred stock units linked to the company’s common stock.

Rhea-AI Summary

Orchid Island Capital director Ava L. Parker reported two routine compensation-related awards of deferred stock units. On June 30, 2026, she acquired 1,679 deferred stock units at a reference price of 6.9700 per unit, and on July 1, 2026 she acquired an additional 3,586 units at no cost. Each deferred stock unit represents a right to receive one share of Orchid Island Capital common stock and is fully vested. These units were issued in lieu of the company’s monthly dividend under Parker’s election and become payable only upon a change of control or upon her death, disability, or separation from service as a director. Following these awards, she holds 122,340 deferred stock units directly.

Rhea-AI Summary

Morabito Paula reported acquisition or exercise transactions in this Form 4 filing.

Orchid Island Capital, Inc. director Paula Morabito received a grant of 3,586 Deferred Stock Units as compensation. Each unit represents the right to receive one share of common stock and is fully vested. These units become payable only upon a change of control or upon her death, disability, or separation from service as a director. Following this award, she holds a total of 55,686 Deferred Stock Units directly.

Rhea-AI Summary

Bitting W Coleman reported acquisition or exercise transactions in this Form 4 filing.

Orchid Island Capital director W. Coleman Bitting received a grant of 3,586 deferred stock units as compensation. Each unit represents the right to receive one share of common stock. Following this award, he holds 53,875 deferred stock units. The units are fully vested but only become payable upon a change of control or his death, disability, or separation from service as a director.

Rhea-AI Summary

Orchid Island Capital CEO Robert E. Cauley exercised performance-based equity awards into 3,694 shares of common stock, stemming from Performance Units granted in 2023 and 2024. Following these vestings, he directly holds 226,984 common shares and 126,995.38 Performance Units, reflecting routine compensation-related equity activity.

Rhea-AI Summary

Orchid Island Capital Chief Financial Officer Haas G. Hunter IV reported routine equity compensation activity involving performance units and common stock. On June 26, 2026, he exercised performance units to acquire 3,031 shares of common stock at $0.00 per share under the company’s equity incentive plans. In connection with this vesting, 1,193 shares of common stock were transferred back to the issuer at $6.86 per share to cover tax withholding obligations, which is not an open-market sale. After these transactions, he directly held 137,522 shares of common stock and 97,939.95 performance units.

Rhea-AI Summary

Parker Ava L reported acquisition or exercise transactions in this Form 4 filing.

Orchid Island Capital director Ava L. Parker reported receiving 1,660 Deferred Stock Units, each representing the right to receive one share of common stock. These units were issued at a reference price of $6.95 per unit.

The award reflects Parker’s election to receive the issuer’s monthly dividend in the form of deferred stock units rather than cash. The units are 100% vested but will only be paid out upon a change of control or upon Parker’s death, disability, or separation from service as a director. Following this grant, Parker holds 117,075 Deferred Stock Units.

Rhea-AI Summary

Orchid Island Capital director Ava L. Parker received 1,877 deferred stock units as a grant in an acquisition-type transaction. The units were issued on April 30, 2026 in lieu of the company’s monthly cash dividend, based on a reference price of $7.03 per unit.

Each deferred stock unit represents the right to receive one share of Orchid Island’s common stock. The units are fully vested, and Parker now holds 115,415 deferred stock units. However, these units will only be paid out in shares upon a change of control or upon her death, disability, or separation from service as a director.

Rhea-AI Summary

FILIPPS FRANK P reported acquisition or exercise transactions in this Form 4 filing.

Orchid Island Capital director Frank P. Filipps received a grant of 3,561 deferred stock units. These units are fully vested and each represents the right to receive one share of common stock. They will be paid only upon a change of control or his death, disability, or separation from service as a director. Following the award, he holds 50,289 deferred stock units in total, reflecting routine non-cash director compensation rather than an open-market share purchase or sale.

Rhea-AI Summary

Bitting W Coleman reported acquisition or exercise transactions in this Form 4 filing.

Orchid Island Capital director Bitting W. Coleman received a routine equity award in the form of deferred stock units. The grant covers 3,561 deferred stock units at a price of $0.00 per unit, each representing the right to receive one share of common stock. Following this award, Coleman holds 50,289 deferred stock units. The units are fully vested but will only be paid in shares upon a change of control or Coleman's death, disability, or separation from service as a director.

Rhea-AI Summary

Morabito Paula reported acquisition or exercise transactions in this Form 4 filing.

Orchid Island Capital director Paula Morabito received 3,561 deferred stock units as a compensation award. Each unit represents the right to receive one share of common stock, bringing her total deferred stock units to 52,100 held directly.

The units are fully vested but will only be paid out in shares upon a change of control of Orchid Island Capital, or upon her death, disability, or separation from service as a director. This filing reflects a routine grant rather than an open-market purchase or sale.

Rhea-AI Summary

Orchid Island Capital director Ava L. Parker reported awards of deferred stock units that increase her equity-based compensation. On March 30, she acquired 1,877 deferred stock units, and on April 1 she acquired 3,561 deferred stock units, each representing one share of common stock.

The units are fully vested but only payable upon a change of control or her death, disability, or separation from service as a director. Following these awards, Parker holds 113,538 deferred stock units, reflecting a larger, long-term alignment with shareholders rather than open-market trading.

Rhea-AI Summary

Orchid Island Capital Chief Financial Officer Haas G. Hunter IV exercised performance-based equity awards into common stock. On March 26, 2026, 3,031.72 Performance Units were converted into 3,031 shares of common stock, reflecting vesting of awards granted in April 2023 and March 2024.

To cover tax withholding tied to this vesting, 1,133 shares were returned to the company at a price of $7.15 per share, equal to the March 25, 2026 closing price. Following these compensation-related transactions, Hunter directly holds 135,684 shares of Orchid Island Capital common stock.

Rhea-AI Summary

Orchid Island Capital CEO Robert E. Cauley exercised performance-based equity awards, receiving 3,694 shares of common stock at a stated price of $0.0000 per share. The transaction reflects the vesting of previously granted Performance Units under the company’s equity incentive plans.

Following these transactions, Cauley directly holds 223,290 shares of Orchid Island Capital common stock. Cash was paid instead of issuing fractional shares, based on the closing share price on March 25, 2026, indicating this is a routine, compensation-related equity settlement rather than an open-market trade.

Rhea-AI Summary

Orchid Island Capital CEO Robert E. Cauley reported routine equity compensation and related tax withholding. He was granted 121,891 performance units, each representing a contingent right to one share of common stock, under the company’s 2021 and 2025 long-term incentive plans.

On the same date, he also received 121,891 unrestricted common shares, and 49,790 common shares were disposed back to the company at a value of $6.82 per share to satisfy tax withholding obligations. After these transactions, he held 219,596 shares of common stock directly.

Rhea-AI Summary

Orchid Island Capital Chief Financial Officer Haas G. Hunter IV reported equity compensation awards and related tax withholding transactions. He was granted 93,184 performance units, each representing a contingent right to receive one share of common stock, bringing his performance unit balance to 104,003.39 units.

On the same date, he also received 93,184 unrestricted shares of common stock at no cost under the company’s equity incentive plans. To satisfy tax withholding obligations from this share award, 36,896 common shares were disposed of back to the company at a price of $6.82 per share, based on the March 20, 2026 closing price.

Following these transactions, Hunter directly owns 133,786 shares of Orchid Island Capital common stock, in addition to his outstanding performance units. The filing reflects routine compensation-related grants and associated tax withholding, rather than open-market purchases or sales.

Rhea-AI Summary

Orchid Island Capital director Ava L. Parker reported an acquisition of 1,680 deferred stock units on February 27, 2026, valued at $7.60 per unit. Her direct holdings in this derivative security increased to 108,100 deferred stock units after the transaction.

Each deferred stock unit represents a right to receive one share of Orchid Island Capital common stock. The units are fully vested but will only be paid out upon a change of control or Parker’s death, disability, or separation from service as a director. They were issued in lieu of the company’s monthly dividend under her prior election.

Rhea-AI Summary

Orchid Island Capital, Inc. director Ava L. Parker reported acquiring 1,559 deferred stock units on 01/30/2026. Each deferred stock unit represents a right to receive one share of Orchid Island’s common stock and was valued at $7.80 per unit.

The units were issued in lieu of the company’s monthly dividend based on Parker’s election. After this transaction, Parker beneficially owned 106,420 deferred stock units, held directly. These units are fully vested but will be paid only upon a change of control or upon Parker’s death, disability, or separation from service as a director.

Rhea-AI Summary

Orchid Island Capital, Inc. director Frank P. Filipps reported an equity compensation transaction involving deferred stock units. On 01/02/2026, he acquired 3,472 deferred stock units, each representing the right to receive one share of Orchid Island Capital common stock. The filing shows these units at a price of $0, reflecting a grant rather than an open-market purchase.

After this grant, Filipps beneficially owns 46,728 deferred stock units, held in direct ownership form. The units are fully vested but will only be paid out in common shares upon the earlier of a change of control of the company or his death, disability, or separation from service as a director. This filing documents the update to his equity-based holdings.

Rhea-AI Summary

Orchid Island Capital director reports additional deferred stock units. A director of Orchid Island Capital, Inc. acquired derivative equity awards in the form of deferred stock units tied to the company’s common stock.

On 12/30/2025, the director received 1,644 deferred stock units at a price of $7.28 per underlying share. On 01/02/2026, the director received another 3,472 deferred stock units at a price of $0, bringing total derivative securities beneficially owned to 104,861 deferred stock units.

Each deferred stock unit represents the right to receive one share of common stock and is fully vested. These units, including those issued in lieu of the company’s monthly dividend at the director’s election, become payable upon a change of control or the director’s death, disability, or separation from service as a director.

Rhea-AI Summary

Orchid Island Capital, Inc. reported that one of its directors received 3,472 deferred stock units on 01/02/2026. Each deferred stock unit represents the right to receive one share of Orchid Island Capital common stock. After this grant, the director beneficially owns 48,539 derivative securities in the form of deferred stock units, held directly.

The deferred stock units are fully vested but will only be paid out in common shares upon the earlier of a change of control of the company, or the director’s death, disability, or separation from service as a director. This structure ties the director’s equity value to the company’s long-term performance and continuity of service.

Rhea-AI Summary

Orchid Island Capital, Inc. reported a routine insider equity award for one of its directors. On 01/02/2026, the director acquired 3,472 deferred stock units at a price of $0 per unit, as shown in the derivative securities table. Each deferred stock unit represents the right to receive one share of Orchid Island Capital common stock.

The deferred stock units are fully vested but will only be paid out upon a change of control of the company or the director’s death, disability, or separation from service as a director. Following this transaction, the director beneficially owns 46,728 derivative securities in the form of deferred stock units, held directly.

Rhea-AI Summary

Orchid Island Capital, Inc. reports that Chief Executive Officer Robert E. Cauley exercised 3,694.18 Performance Units into common stock on December 26, 2025, following awards granted in 2023 and 2024 under the company’s equity incentive plans. In connection with this vesting, 753 common shares were delivered back to the issuer at $7.35 per share to satisfy tax-withholding obligations, a price equal to the December 24, 2025 closing price. After these transactions, Cauley directly holds 147,495 shares of Orchid Island common stock.

Rhea-AI Summary

Orchid Island Capital, Inc. director and Chief Financial Officer G. Hunter Haas IV reported equity award activity in company stock. On 12/26/2025, performance units converted into 3,031 shares of common stock at an exercise price of $0, reflecting vesting of prior awards under the company’s equity incentive plans. On the same date, he disposed of 1,133 shares back to the company at $7.35 per share to cover tax withholding related to the vesting. Following these transactions, he directly holds 77,498 shares of common stock and 10,819.39 performance units.

Rhea-AI Summary

Orchid Island Capital, Inc. director Ava Parker reported receiving 1,615 deferred stock units on 11/28/2025. Each deferred stock unit represents one share of Orchid Island Capital common stock and was issued in lieu of the company’s monthly dividend under Parker’s prior election. The units are fully vested but will not be paid out until the earlier of a change of control or Parker’s death, disability, or separation from service as a director. Following this transaction, Parker beneficially owns 99,745 derivative securities in the form of deferred stock units, held directly.